HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Found 187 products of "HBV"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
BA-53038B
CAS:BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM).Formula:C14H16ClNOColor and Shape:SolidMolecular weight:249.74HBV-IN-25
CAS:HBV-IN-25: oral HBV cccDNA reducer, anti-HBeAg, anti-HBV (IC50: 0.58/1.15 μM), soluble (>452 μg/mL), non-toxic.Formula:C18H14ClNO4Color and Shape:SolidMolecular weight:343.76Fosclevudine alafenamide
CAS:Fosclevudine alafenamide (Compound EIDD-02173) is an antiviral agent that acts against HBV (EC50: 1.71 μM).Formula:C22H29FN3O9PColor and Shape:SolidMolecular weight:529.45L-Fd4A
CAS:L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.Formula:C10H10FN5O2Color and Shape:SolidMolecular weight:251.22(5S,8R)-HBV-IN-10
CAS:'(5S,8R)-HBV-IN-10 is an EC50 0.1-1 μM HBsAg inhibitor, isomer of compound 6 from patent WO2021204258A1.Formula:C23H24FN7OColor and Shape:SolidMolecular weight:433.48Isothiafludine
CAS:Isothiafludine is a HBV virus inhibitor that dramatically reduces the HBV DNA level in cells.Formula:C18H18FN3OS2Purity:99.71%Color and Shape:SolidMolecular weight:375.48Pradefovir
CAS:Pradefovir (Remofovir) is a prodrug for chronic HBV, converting to PMEA in the liver with a Km of 60 μM and clearance of 359 ml/min.Formula:C17H19ClN5O4PPurity:97.50%Color and Shape:SolidMolecular weight:423.79Besifovir PM
Besifovir PM (LB80331 PM) is an analogue of Besifovir, a novel orally available acyclic nucleotide phosphonate for the treatment of chronic hepatitis B
Formula:C11H15N5OPurity:98.48% - 99.90%Color and Shape:SoildMolecular weight:233.27Bersacapavir
CAS:Bersacapavir (JNJ-56136379) is an in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.Formula:C16H14F4N4O3SPurity:98.53%Color and Shape:SolidMolecular weight:418.37Tobevibart
CAS:Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].Purity:98%Color and Shape:LiquidHBV-IN-8
CAS:HBV-IN-6 is a potent inhibitor of HBV (EC50: 287.9 nM).Formula:C21H25ClFN5O5S2Color and Shape:SolidMolecular weight:546.04HBF-0259
CAS:HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.Formula:C16H12Cl2FN5Purity:98.07% - 99.42%Color and Shape:SolidMolecular weight:364.2Ref: TM-T27527
2mg34.00€5mg49.00€1mL*10mM (DMSO)50.00€10mg71.00€25mg114.00€50mg172.00€100mg249.00€200mg349.00€HBV-IN-41
CAS:HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].Formula:C18H19ClFN5O3Purity:98%Color and Shape:SolidMolecular weight:407.83Valtorcitabine dihydrochloride
CAS:Valtorcitabine dihydrochloride, a DNA polymerase inhibitor, is used potentially for the treatment of HBV infection.Formula:C14H24Cl2N4O5Color and Shape:SolidMolecular weight:399.27HEC72702
CAS:HEC72702: New HBV capsid inhibitor, from GLS4. No CYP1A2, CYP3A4, CYP2B6 induction at 10μM.Formula:C24H26BrFN4O5SColor and Shape:SolidMolecular weight:581.45ent-Entecavir
CAS:Ent-Entecavir, an enantiomeric impurity of Entecavir (an oral HBV drug), inhibits HBV replication as a reverse transcriptase inhibitor.Formula:C12H15N5O3Color and Shape:SolidMolecular weight:277.28IR415
CAS:IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBxFormula:C13H14F2N4SPurity:99.85%Color and Shape:SolidMolecular weight:296.34Ref: TM-T11669
5mg43.00€1mL*10mM (DMSO)47.00€10mg71.00€25mg128.00€50mg215.00€100mg318.00€200mg444.00€AB-836
CAS:AB-836, an orally active hepatitis B virus (HBV) capsid inhibitor, hampers viral replication by engaging with the HBV core protein.Formula:C20H15F3N4O2Color and Shape:SolidMolecular weight:400.35Emtricitabine triphosphate tetrasodium salt
CAS:Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of the phosphorylated anabolite (-)-Emtricitabine triphosphate, an active nucleosideFormula:C8H9FN3Na4O12P3SPurity:98%Color and Shape:SolidMolecular weight:575.11Carbovir
CAS:Carbovir, an NRTI, induces mitochondrial toxicity in human liver cancer cells.Formula:C11H13N5O2Color and Shape:SolidMolecular weight:247.25
